Related references
Note: Only part of the references are listed.Analysis of the improvement of serological indexes in patients with diabetic nephropathy and hypertension using Valsartan combined with Nifedipine controlled-release regimen
Lili Cai et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2022)
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Nur Samsu
BIOMED RESEARCH INTERNATIONAL (2021)
Inflammatory Targets in Diabetic Nephropathy
Javier Donate-Correa et al.
JOURNAL OF CLINICAL MEDICINE (2020)
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger et al.
HYPERTENSION (2020)
Inflammation in Diabetic Kidney Disease
Rosa E. Perez-Morales et al.
NEPHRON (2019)
Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension
Tzung-Dau Wang et al.
HYPERTENSION (2017)
Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group
Umberto Maggiore et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Hillel Sternlicht et al.
BLOOD PURIFICATION (2016)
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
Scott A. Hubers et al.
CIRCULATION (2016)
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes
Salvatore De Cosmo et al.
JOURNAL OF HYPERTENSION (2016)
Trends in Chronic Kidney Disease in China
Luxia Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Evaluation of 12 Novel Molecular Markers for Degenerated Nucleus Pulposus in a Chinese Population
Shuai Chen et al.
SPINE (2015)
The meaning of the blood urea nitrogen/creatinine ratio in acute kidney injury
Shigehiko Uchino et al.
CLINICAL KIDNEY JOURNAL (2012)
Valsartan use in pediatric hypertension
Kevin E. C. Meyers et al.
FUTURE CARDIOLOGY (2011)
The Role of Natriuretic Peptides in Inflammation and Immunity
Brian P. Casserly et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2010)
Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine
Kana Tsukuda et al.
HYPERTENSION (2008)
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
J. A. Jefferson et al.
KIDNEY INTERNATIONAL (2008)
Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease
Robert Toto et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Diabetic nephropathy: Diagnosis, prevention, and treatment
JL Gross et al.
DIABETES CARE (2005)
Progression to overt nephropathy in type 2 diabetes - The Casale Monferrato study
G Bruno et al.
DIABETES CARE (2003)
Share Paper
